{"DataElement":{"publicId":"4541175","version":"1","preferredName":"Hematopoietic Cell Transplantation Donor Cellular Infusion Mismatch Level Type","preferredDefinition":"the type of level mismatch lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted.","longName":"HCTDnrClMisLvlTp","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"4526377","version":"1","preferredName":"Hematopoietic Cell Transplantation Donor Cellular Infusion Mismatch Finding","preferredDefinition":"information related to the failure result to match lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted.","longName":"HCTDnrClMisFd","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2659877","version":"1","preferredName":"Stem Cell Transplantation","preferredDefinition":"A method of replacing the immature blood-forming cells lost due to high-dose chemotherapy, and possibly radiation therapy, used to destroy leukemia cells.  The stem cells are given to the patient after treatment to help the bone marrow recover and continue producing healthy blood cells.","longName":"C15431","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Cell Transplantation","conceptCode":"C15431","definition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BBDBD7-E7FD-4A2E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2007-06-25","modifiedBy":"ONEDATA","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4541271","version":"1","preferredName":"Donor Cellular Infusion Mismatch Finding","preferredDefinition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation.:A failure to correspond or match; to match unsuitably or inaccurately.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"C77273:C67078:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Donor Cellular Infusion","conceptCode":"C77273","definition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mismatch","conceptCode":"C67078","definition":"A failure to correspond or match; to match unsuitably or inaccurately.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05A5ABF0-0F62-52A6-E050-BB89AD43294D","latestVersionIndicator":"Yes","beginDate":"2014-10-17","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-17","modifiedBy":"ONEDATA","dateModified":"2014-10-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"04F09911-3485-904E-E050-BB89AD431B73","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-08","modifiedBy":"MAESKEB","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4541173","version":"1","preferredName":"Cellular Infusion Mismatch Level Type","preferredDefinition":"the type of mismatch level of lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted.","longName":"ClMisLvlTp","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Antigen","valueDescription":"Antigen","ValueMeaning":{"publicId":"3167779","version":"1","preferredName":"Antigen","longName":"3167779","preferredDefinition":"Any substance that appears foreign or potentially adverse to the body and elicits immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antigen","conceptCode":"C268","definition":"Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"977E0E2F-20C3-9A91-E040-BB89AD434AE4","latestVersionIndicator":"Yes","beginDate":"2010-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05A38DC6-FD4C-1F86-E050-BB89AD436B96","beginDate":"2014-10-17","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-17","modifiedBy":"ONEDATA","dateModified":"2014-10-17","deletedIndicator":"No"},{"value":"Allele","valueDescription":"Allele","ValueMeaning":{"publicId":"4541174","version":"1","preferredName":"Allele","longName":"4541174","preferredDefinition":"Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allele","conceptCode":"C16277","definition":"Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05A38DC6-FD57-1F86-E050-BB89AD436B96","latestVersionIndicator":"Yes","beginDate":"2014-10-17","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-17","modifiedBy":"COOPERM","dateModified":"2018-03-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05A38DC6-FD70-1F86-E050-BB89AD436B96","beginDate":"2014-10-17","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-17","modifiedBy":"ONEDATA","dateModified":"2014-10-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05A38DC6-FD38-1F86-E050-BB89AD436B96","latestVersionIndicator":"Yes","beginDate":"2014-10-17","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-17","modifiedBy":"WONGW","dateModified":"2014-10-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"At what level was the mismatc","type":"Preferred Question Text","description":"At what level was the mismatch?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05A38DC6-FD80-1F86-E050-BB89AD436B96","latestVersionIndicator":"Yes","beginDate":"2014-10-17","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-17","modifiedBy":"WONGW","dateModified":"2014-10-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}